CUSTOMIZABLE LYOPHILIZED AGENT FOR IMAGE-GUIDED RADIOTHERAPY AND DRUG DELIVERY

ENHANCED MSC PREPARATIONS

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

PSMA LIGAND TARGETED COMPOUNDS AND USES THEREOF

LEAD (II)-CONTAINING NANOPARTICLES AS X-RAY CONTRAST AGENTS DISPERSED IN ALGINATE GELS

COMPLEX, VASCULAR CONTRAST AGENT, X-RAY CONTRAST AGENT, METHOD FOR PRODUCING COMPLEX, AND IMAGING METHOD FOR CAPTURING STRUCTURAL CHANGE IN VESSEL

ENHANCED MSC PREPARATIONS

TUMOR IMAGING WITH X-RAYS AND OTHER HIGH ENERGY SOURCES USING AS CONTRAST AGENTS PHOTON-EMITTING PHOSPHORS HAVING THERAPEUTIC PROPERTIES

SYSTEM AND METHODS FOR QUANTIFICATION OF SUBSTANCE CONCENTRATION IN BODY STRUCTURES USING SPECTRAL COMPUTED TOMOGRAPHY

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

METHOD, DEVICE AND MARKER SUBSTANCE KIT FOR MULTI-PARAMETRIC X-RAY FLUORESCENCE IMAGING

RADIOPAQUE PARTICLE COMPOSITIONS AND USES THEREOF

Radiographic Contrast Agents For Temporal Subtraction And Dual-Energy X-Ray Imaging

PSMA ligand targeted compounds and uses thereof

NANOPARTICLES AND COMPOSITIONS FOR BIOLOGICAL IMAGING BASED ON X-RAY ATTENUATION

Theranostic Radiophotodynamic Therapy Nanoparticles

Bi-dota complex-loaded dendritic polymer nanoparticles

Enhanced MSC preparations

Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties

Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms

Porphyrin modified telodendrimers

Bi-DOTA complex-loaded dendritic polymer nanoparticles

COMPOSITIONS AND METHODS FOR USE IN ONCOLOGY

DRUG DESIGN FOR APPLICATION-DEPENDENT PAYLOAD, CONTROLLED PHARMACOKINETIC DISTRIBUTION, AND RENAL CLEARANCE

DRUG DESIGN FOR APPLICATION-DEPENDENT PAYLOAD, CONTROLLED PHARMACOKINETIC DISTRIBUTION, AND RENAL CLEARANCE

PSMA ligands and uses thereof

METHOD FOR IMAGING AN EXAMINATION REGION HAVING FIRST CONTRAST MEDIUM AND SECOND CONTRAST MEDIUM

Enhanced MSC preparation

Stimuli-responsive magneto-plasmonic nanocarrier

Phosphor-containing drug activator activatable by a Monte Carlo derived x-ray exposure, system containing the activator, and methods for use

PORPHYRIN MODIFIED TELODENDRIMERS

POLYMER MICROBUBBLES AS X-RAY DARK FIELD CONTRAST AGENTS

Compositions for nanoconfinement induced contrast enhancement and methods of making and using thereof

Biopolymer-nanoparticle composite implant for tumor cell tracking

Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties

X-ray micro imaging

Compositions and methods for use in medical diagnosis

Porphyrin modified telodendrimers

Radiographic contrast agents for temporal subtraction and dual-energy x-ray imaging

PSMA ligands and uses thereof

X-ray Excited Optical Materials and Methods for High Resolution Chemical Imaging

Polypeptide and imaging method

Star polymer nanoshells and methods of preparation thereof

Protein-based nanobubble x-ray imaging method and agent

Bile acid oligomer conjugate for novel vesicular transport and use thereof

Inorganic powder coated with biocompatible polymer, and cosmetic composition comprising same

Enhanced MSC preparations

Activatable particles, preparation and uses

Non-invasive method and system for detection of cancer or arterial vascular disorders using metal nanoparticles

Liquids and gels for the ophthalmology and microscopy system for observing the same

Bismuth particle X-ray contrast agents

Medicinal agent for medical applications

Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

Porphyrin modified telodendrimers

Enhanced MSC preparations

SYSTEMS AND METHODS FOR X-RAY FLUORESCENCE COMPUTED TOMOGRAPHY IMAGING WITH NANOPARTICLES

Star polymer nanoshells and methods of preparation thereof

ENHANCED MSC PREPARATIONS

NANOPARTICLE-LOADED CELLS

Methods and systems for inducing immunologic tolerance to non-self antigens

Innately multimodal nanoparticles

CONTROL OF THE TOXICITY OF GOLD NANOPARTICLES

NANOPARTICLE LABELING AND SYSTEM USING NANOPARTICLE LABELING

Selenium containing modifying agents and conjugates

Particles with radiation activated adhesive

Multimodal nanoparticles for non-invasive bio-imaging

Diagnosis and treatment method of malignant tumours and marker compound

PREPARATION OF CARBON NANOTUBES WITH LANTHANOID CATALYSTS

QUANTUM DOT LABELED STEM CELLS FOR USE IN CARDIAC REPAIR

NANOTRACER FOR IN-SITU GASTRIC CANCER DETECTION

Multimodal imaging using a three compartment polymer nanoparticle with cell specificity

Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same

Multifunctional metal-graphite nanocrystals

Nanoparticles and their use for multifunctional bioimaging

Contrast Agent for Medical Imaging Techniques and Usage Thereof

Cell and sub-cell methods for imaging and therapy

Activatable particles, preparations and uses

Process for preparing dispersible sulfate, preferably barium sulfate nanoparticles

NANOPARTICLE-BASED IMAGING AGENTS FOR X-RAY / COMPUTED TOMOGRAPHY AND METHODS FOR MAKING SAME

Nanoparticle-based imaging agents for X-ray/computed tomography

Nanoparticle-based imaging agents for X-ray/computed tomography

Nanoparticle-based imaging agents for X-ray/computed tomography

Method for producing alkaline earth sulphate nanoparticles

Biodegradable embolic agents